Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced nonalcoholic fatty liver

Cell Metabolism

Volumn 17, Issue 4, 2013, Pages 586-598

  Chaveroux, Cédric ^a   Eichner, Lillian J ^a   Dufour, Catherine R ^a   Shatnawi, Aymen ^a   Khoutorsky, Arkady ^a   Bourque, Guillaume ^b   Sonenberg, Nahum ^a,b   Giguère, Vincent ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RELATED RECEPTOR ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; PROTEASOME; RAPAMYCIN; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CITRIC ACID CYCLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENERGY METABOLISM; GENE EXPRESSION; GENETIC ASSOCIATION; HYPERLIPIDEMIA; LIPOGENESIS; MALE; MOLECULAR BIOLOGY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAPAMYCIN INDUCED NONALCOHOLIC FATTY LIVER; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CHROMATIN IMMUNOPRECIPITATION; CITRIC ACID CYCLE; FATTY LIVER; GENE REGULATORY NETWORKS; HELA CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN INTERACTION MAPS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC; UBIQUITIN;

MUS;

EID: 84875909085     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.03.003     Document Type: Article

References (46)

1. R.A. Bachmann, J.H. Kim, A.L. Wu, I.H. Park, and J. Chen A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1 J. Biol. Chem. 281 2006 7357 7363
2. P.G. Blanchard, W.T. Festuccia, V.P. Houde, P. St-Pierre, S. Brûlé, V. Turcotte, M. Côté, K. Bellmann, A. Marette, and Y. Deshaies Major involvement of mTOR in the PPARγ-induced stimulation of adipose tissue lipid uptake and fat accretion J. Lipid Res. 53 2012 1117 1125
3. S.M. Blättler, J.T. Cunningham, F. Verdeguer, H. Chim, W. Haas, H. Liu, K. Romanino, M.A. Rüegg, S.P. Gygi, Y. Shi, and P. Puigserver Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling Cell Metab. 15 2012 505 517
4. L. Carrière, S. Graziani, O. Alibert, Y. Ghavi-Helm, F. Boussouar, H. Humbertclaude, S. Jounier, J.C. Aude, C. Keime, and J. Murvai Genomic binding of Pol III transcription machinery and relationship with TFIIS transcription factor distribution in mouse embryonic stem cells Nucleic Acids Res. 40 2012 270 283
5. A. Charest-Marcotte, C.R. Dufour, B.J. Wilson, A.M. Tremblay, L.J. Eichner, D.H. Arlow, V.K. Mootha, and V. Giguère The homeobox protein Prox1 is a negative modulator of ERRα/PGC-1α bioenergetic functions Genes Dev. 24 2010 537 542
6. N. Chotechuang, D. Azzout-Marniche, C. Bos, C. Chaumontet, C. Gaudichon, and D. Tomé Down-regulation of the ubiquitin-proteasome proteolysis system by amino acids and insulin involves the adenosine monophosphate-activated protein kinase and mammalian target of rapamycin pathways in rat hepatocytes Amino Acids 41 2011 457 468
7. P. Cohen, M. Miyazaki, N.D. Socci, A. Hagge-Greenberg, W. Liedtke, A.A. Soukas, R. Sharma, L.C. Hudgins, J.M. Ntambi, and J.M. Friedman Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss Science 297 2002 240 243
8. J.T. Cunningham, J.T. Rodgers, D.H. Arlow, F. Vazquez, V.K. Mootha, and P. Puigserver mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex Nature 450 2007 736 740
9. G. Deblois, and V. Giguère Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease Biochim. Biophys. Acta 1812 2011 1032 1040
10. C.R. Dufour, M.-P. Levasseur, N.H.H. Pham, L.J. Eichner, B.J. Wilson, A. Charest-Marcotte, D. Duguay, J.-F. Poirier-Héon, N. Cermakian, and V. Giguère Genomic convergence among ERRα, PROX1, and BMAL1 in the control of metabolic clock outputs PLoS Genet. 7 2011 e1002143
11. L.J. Eichner, and V. Giguère Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks Mitochondrion 11 2011 544 552
12. P. García-Morales, E. Hernando, E. Carrasco-García, M.P. Menéndez-Gutierrez, M. Saceda, and I. Martínez-Lacaci Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells Mol. Cancer Ther. 5 2006 2172 2181
13. V. Giguère Transcriptional control of energy homeostasis by the estrogen-related receptors Endocr. Rev. 29 2008 677 696
14. P. Gulati, and G. Thomas Nutrient sensing in the mTOR/S6K1 signalling pathway Biochem. Soc. Trans. 35 2007 236 238
15. P. Gulati, L.D. Gaspers, S.G. Dann, M. Joaquin, T. Nobukuni, F. Natt, S.C. Kozma, A.P. Thomas, and G. Thomas Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34 Cell Metab. 7 2008 456 465
16. C. Handschin, and V.K. Mootha Estrogen-related receptor α (ERRα): A novel target in type 2 diabetes Drug Discov. Today Ther. Strateg. 2 2005 151 156
17. R.K. Harston, J.C. McKillop, P.C. Moschella, A. Van Laer, L.S. Quinones, C.F. Baicu, S. Balasubramanian, M.R. Zile, and D. Kuppuswamy Rapamycin treatment augments both protein ubiquitination and Akt activation in pressure-overloaded rat myocardium Am. J. Physiol. Heart Circ. Physiol. 300 2011 H1696 H1706
18. V.P. Houde, S. Brûlé, W.T. Festuccia, P.G. Blanchard, K. Bellmann, Y. Deshaies, and A. Marette Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue Diabetes 59 2010 1338 1348
19. K. Inoki, J. Kim, and K.L. Guan AMPK and mTOR in cellular energy homeostasis and drug targets Annu. Rev. Pharmacol. Toxicol. 52 2012 381 400
20. H.K. Jin, S.H. Ahn, J.W. Yoon, J.W. Park, E.K. Lee, J.S. Yoo, J.C. Lee, W.S. Choi, and J.W. Han Rapamycin down-regulates inducible nitric oxide synthase by inducing proteasomal degradation Biol. Pharm. Bull. 32 2009 988 992
21. T. Kantidakis, B.A. Ramsbottom, J.L. Birch, S.N. Dowding, and R.J. White mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1 Proc. Natl. Acad. Sci. USA 107 2010 11823 11828
22. J.E. Kim, and J. Chen Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation Proc. Natl. Acad. Sci. USA 97 2000 14340 14345
23. J. Kim, M. Kundu, B. Viollet, and K.L. Guan AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 Nat. Cell Biol. 13 2011 132 141
24. G. Levy, H. Schmidli, J. Punch, E. Tuttle-Newhall, D. Mayer, P. Neuhaus, D. Samuel, B. Nashan, J. Klempnauer, and A. Langnas Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results Liver Transpl. 12 2006 1640 1648
25. H. Li, C.K. Tsang, M. Watkins, P.G. Bertram, and X.F. Zheng Nutrient regulates Tor1 nuclear localization and association with rDNA promoter Nature 442 2006 1058 1061
26. J. Luo, R. Sladek, J. Carrier, J.-A. Bader, D. Richard, and V. Giguère Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor α Mol. Cell. Biol. 23 2003 7947 7956
27. J.D. Morrisett, G. Abdel-Fattah, R. Hoogeveen, E. Mitchell, C.M. Ballantyne, H.J. Pownall, A.R. Opekun, J.S. Jaffe, S. Oppermann, and B.D. Kahan Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients J. Lipid Res. 43 2002 1170 1180
28. R.J. Patch, L.L. Searle, A.J. Kim, D. De, X. Zhu, H.B. Askari, J.C. O'Neill, M.C. Abad, D. Rentzeperis, and J. Liu Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents J. Med. Chem. 54 2011 788 808
29. E. Patsenker, V. Schneider, M. Ledermann, H. Saegesser, C. Dorn, C. Hellerbrand, and F. Stickel Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis J. Hepatol. 55 2011 388 398
30. T. Peng, T.R. Golub, and D.M. Sabatini The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation Mol. Cell. Biol. 22 2002 5575 5584
31. T.R. Peterson, S.S. Sengupta, T.E. Harris, A.E. Carmack, S.A. Kang, E. Balderas, D.A. Guertin, K.L. Madden, A.E. Carpenter, B.N. Finck, and D.M. Sabatini mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway Cell 146 2011 408 420
32. T. Porstmann, C.R. Santos, B. Griffiths, M. Cully, M. Wu, S. Leevers, J.R. Griffiths, Y.L. Chung, and A. Schulze SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth Cell Metab. 8 2008 224 236
33. V. Risson, L. Mazelin, M. Roceri, H. Sanchez, V. Moncollin, C. Corneloup, H. Richard-Bulteau, A. Vignaud, D. Baas, and A. Defour Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy J. Cell Biol. 187 2009 859 874
34. M. Rosner, and M. Hengstschläger Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1 Hum. Mol. Genet. 17 2008 2934 2948
35. D.D. Sarbassov, S.M. Ali, S. Sengupta, J.H. Sheen, P.P. Hsu, A.F. Bagley, A.L. Markhard, and D.M. Sabatini Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Mol. Cell 22 2006 159 168
36. B. Shor, J. Wu, Q. Shakey, L. Toral-Barza, C. Shi, M. Follettie, and K. Yu Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells J. Biol. Chem. 285 2010 15380 15392
37. R. Sladek, J.-A. Bader, and V. Giguère The orphan nuclear receptor estrogen-related receptor α is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene Mol. Cell. Biol. 17 1997 5400 5409
38. N. Sonenberg, and A.G. Hinnebusch Regulation of translation initiation in eukaryotes: mechanisms and biological targets Cell 136 2009 731 745
39. C.K. Tsang, H. Liu, and X.F. Zheng mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes Cell Cycle 9 2010 953 957
40. R.B. Vega, and D.P. Kelly A role for estrogen-related receptor α in the control of mitochondrial fatty acid β-oxidation during brown adipocyte differentiation J. Biol. Chem. 272 1997 31693 31699
41. J.A. Villena, and A. Kralli ERRalpha: a metabolic function for the oldest orphan Trends Endocrinol. Metab. 19 2008 269 276
42. S. Wullschleger, R. Loewith, and M.N. Hall TOR signaling in growth and metabolism Cell 124 2006 471 484
43. Y. Yamauchi, K. Furukawa, K. Hamamura, and K. Furukawa Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen Cancer Res. 71 2011 4989 4997
44. S.B. Yang, H.Y. Lee, D.M. Young, A.C. Tien, A. Rowson-Baldwin, Y.Y. Shu, Y.N. Jan, and L.Y. Jan Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity J. Mol. Med. 90 2012 575 585
45. L. Yu, C.K. McPhee, L. Zheng, G.A. Mardones, Y. Rong, J. Peng, N. Mi, Y. Zhao, Z. Liu, and F. Wan Termination of autophagy and reformation of lysosomes regulated by mTOR Nature 465 2010 942 946
46. X. Zhang, L. Shu, H. Hosoi, K.G. Murti, and P.J. Houghton Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture J. Biol. Chem. 277 2002 28127 28134